Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.04 | 0.7 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |